329 related articles for article (PubMed ID: 9625011)
1. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
3. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
Transplant Proc; 1998 Mar; 30(2):463-4. PubMed ID: 9532129
[No Abstract] [Full Text] [Related]
5. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
[No Abstract] [Full Text] [Related]
6. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
7. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
[TBL] [Abstract][Full Text] [Related]
8. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
[TBL] [Abstract][Full Text] [Related]
10. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.
Okitsu T; Bartlett ST; Hadley GA; Drachenberg CB; Farney AC
Am J Transplant; 2001 Jul; 1(2):138-45. PubMed ID: 12099361
[TBL] [Abstract][Full Text] [Related]
11. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
[No Abstract] [Full Text] [Related]
13. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
14. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
Lakey JR; Singh B; Warnock GL; Rajotte RV
Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
[TBL] [Abstract][Full Text] [Related]
15. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
16. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model.
Wennberg L; Karlsson-Parra A; Sundberg B; Rafael E; Liu J; Zhu S; Groth CG; Korsgren O
Transplantation; 1997 May; 63(9):1234-42. PubMed ID: 9158015
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
Zhang L; Qi Z; Wu D; Shan S; Ekberg H
Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.
Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW
Transplantation; 1997 Mar; 63(5):716-21. PubMed ID: 9075844
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide.
Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Williams JW
Transplantation; 1997 Mar; 63(5):711-6. PubMed ID: 9075843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
